Mobilization of Hematopoietic Stem and Progenitor Cells Using Inhibitors of CXCR4 and VLA-4

Por Rettig, Michael P., Ansstas, George, DiPersio, John F.
Publicado em 2011

BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells

Por Ramirez, Pablo, Rettig, Michael P., Uy, Geoffrey L., Deych, Elena, Holt, Matthew S., Ritchey, Julie K., DiPersio, John F.
Publicado em 2009

Bortezomib is a rapid mobilizer of hematopoietic stem cells in mice via modulation of the VCAM-1/VLA-4 axis

Por Ghobadi, Armin, Rettig, Michael P., Cooper, Matthew L., Holt, Matthew S., Ritchey, Julie K., Eissenberg, Linda, DiPersio, John F.
Publicado em 2014

Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100

Por Nervi, Bruno, Ramirez, Pablo, Rettig, Michael P., Uy, Geoffrey L., Holt, Matthew S., Ritchey, Julie K., Prior, Julie L., Piwnica-Worms, David, Bridger, Gary, Ley, Timothy J., DiPersio, John F.
Publicado em 2009

Factors Affecting Human T Cell Engraftment, Trafficking and Associated Xenogeneic Graft-Versus-Host Disease in NOD/SCID beta2m(null) Mice

Por Nervi, Bruno, Rettig, Michael P., Ritchey, Julie K., Wang, Hanlin L., Bauer, Gerhard, Walker, Jon, Bonyhadi, Mark L., Berenson, Ronald J., Prior, Julie L., Piwnica-Worms, David, Nolta, Jan A., DiPersio, John F.
Publicado em 2007

Severe Cytokine Release Syndrome Following T-cell Replete Peripheral Blood Haploidentical Donor Transplant is Associated with Poor Survival and Anti-IL-6 Therapy is Safe and Well T...

Por Abboud, Ramzi, Keller, Jesse, Slade, Michael, DiPersio, John F., Westervelt, Peter, Rettig, Michael P., Meier, Stephanie, Fehniger, Todd A., Abboud, Camille N., Uy, Geoffrey L, Vij, Ravi, Trinkaus, Kathryn M., Schroeder, Mark A., Romee, Rizwan
Publicado no Biol Blood Marrow Transplant (2016)

Enhanced in utero allogeneic engraftment in mice after mobilizing fetal HSCs by α4β1/7 inhibition

Por Kim, Aimee G., Vrecenak, Jesse D., Boelig, Matthew M., Eissenberg, Linda, Rettig, Michael P., Riley, John S., Holt, Matthew S., Conner, Michael A., Loukogeorgakis, Stavros P., Li, Haiying, DiPersio, John F., Flake, Alan W., Peranteau, William H.
Publicado no Blood (2016)

A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia

Por Uy, Geoffrey L., Rettig, Michael P., Motabi, Ibraheem H., McFarland, Kyle, Trinkaus, Kathryn M., Hladnik, Lindsay M., Kulkarni, Shashikant, Abboud, Camille N., Cashen, Amanda F., Stockerl-Goldstein, Keith E., Vij, Ravi, Westervelt, Peter, DiPersio, John F.
Publicado em 2012

Targeting CD123 in acute myeloid leukemia using a T-cell–directed dual-affinity retargeting platform

Por Al-Hussaini, Muneera, Rettig, Michael P., Ritchey, Julie K., Karpova, Darja, Uy, Geoffrey L., Eissenberg, Linda G., Gao, Feng, Eades, William C., Bonvini, Ezio, Chichili, Gurunadh R., Moore, Paul A., Johnson, Syd, Collins, Lynne, DiPersio, John F.
Publicado no Blood (2016)

[(18)F]FHBG PET/CT Imaging of CD34-TK75 Transduced Donor T Cells in Relapsed Allogeneic Stem Cell Transplant Patients: Safety and Feasibility

Por Eissenberg, Linda G, Rettig, Michael P, Ritchey, Julie K, Prior, Julie L, Schwarz, Sally W, Frye, Jennifer, White, Brian S, Fulton, Robert S, Ghobadi, Armin, Cooper, Matthew L, Couriel, Daniel R, Seegulam, Muhammad Esa, Piwnica-Worms, David, Dehdashti, Farrokh, Cornetta, Kenneth, DiPersio, John F
Publicado no Mol Ther (2015)